Anton Zhiyanov
- Lecturer:Faculty of Biology and Biotechnology / Joint Department with RAS Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry
- Research Fellow:Faculty of Biology and Biotechnology / Laboratory of Molecular Physiology
- Anton Zhiyanov has been at HSE University since 2020.
Courses (2023/2024)
Bioinformatics (Bachelor’s programme; Faculty of Biology and Biotechnology; field of study "06.03.01. Биология", field of study "06.03.01. Биология"; 2 year, 3, 4 module)Rus
- Theory of Probability and Mathematical Statistics (Bachelor’s programme; Faculty of Biology and Biotechnology; 2 year, 1, 2 module)Rus
- Past Courses
Courses (2022/2023)
- Bioinformatics (Bachelor’s programme; Faculty of Biology and Biotechnology; 2 year, 3, 4 module)Rus
- Probability Theory and Mathematical Statistics (Bachelor’s programme; Faculty of Biology and Biotechnology; 2 year, 1, 2 module)Rus
Courses (2021/2022)
- Probability Theory and Mathematical Statistics (Bachelor’s programme; Faculty of Biology and Biotechnology; 3 year, 2, 3 module)Rus
- Probability Theory and Mathematical Statistics (Bachelor’s programme; Faculty of Biology and Biotechnology; 2 year, 1, 2 module)Rus
Publications10
- Article Zhiyanov A., Narek Engibaryan, Nersisyan S., Shkurnikov M., Tonevitsky A. Differential co-expression network analysis with DCoNA reveals isomiR targeting aberrations in prostate cancer // Bioinformatics. 2023. Vol. 39. No. 2. Article btad051. doi
- Article Zhiyanov A., Shkurnikov M., Nersisyan A., Hui C., Baranova A., Tonevitsky A. The signature of SARS-CoV-2 evolution reflects selective pressures within human guts // Journal of Medical Virology. 2023. Vol. 95. No. 8. Article e28996. doi
- Article Янова М. Р., Жиянов А. П., Антипенко И. Д., Слободов С. А., Степанова Е. В. Уровень внутриклеточного монофосфата гемцитабина предсказывает эффективность химиотерапии с использованием гемцитабина у больных раком мочевого пузыря // Доклады российской академии наук. Науки о жизни. 2023. Т. 513. С. 65-69. doi
- Article Nersisyan S., Zhiyanov A., Еngibaryan N., Maltseva D., Tonevitsky A. A novel approach for a joint analysis of isomiR and mRNA expression data reveals features of isomiR targeting in breast cancer // Frontiers in Genetics. 2022. Vol. 13. Article 1070528. doi
- Article Nersisyan S., Zhiyanov A., Zakharova M., Ishina I., Kurbatskaia I., Mamedov A., Galatenko A. V., Shkurnikov M., Gabibov A., Tonevitsky A. Alterations in SARS-CoV-2 Omicron and Delta peptides presentation by HLA molecules // PeerJ. 2022. Vol. 10. Article e13354. doi
- Article Nersisyan S., Zhiyanov A., Shkurnikov M., Tonevitsky A. T-CoV: a comprehensive portal of HLA-peptide interactions affected by SARS-CoV-2 mutations // Nucleic Acids Research. 2022. Vol. 50. No. D1. P. D883-D887. doi
- Article Nersisyan S., Gorbonos A., Alexey Makhonin, Zhiyanov A., Shkurnikov M., Tonevitsky A. isomiRTar: a comprehensive portal of pan-cancer 5′-isomiR targeting // PeerJ. 2022. Vol. 10. Article e14205. doi
- Article Райгородская М. П., Жиянов А. П., Аверинская Д. А., Тоневицкий Е. А. ИЗМЕНЕНИЕ ЭКСПРЕССИИ ИЗОФОРМ МИКРОРНК И ИХ МИШЕНЕЙ ПРИ ГИПОКСИИ В КЛЕТКАХ HT-29 // Клеточные технологии в биологии и медицине. 2022. № 1. С. 14-18. doi
- Article Жиянов А. П., Шкурников М. Ю. Мутации SARS-CoV-2 приводят к снижению числа регионов связывания с микроРНК ткани лёгких // Клеточные технологии в биологии и медицине. 2022. № 4. С. 216-221. doi
- Article Zhiyanov A., Nersisyan S., Tonevitsky A. Hairpin sequence and structure is associated with features of isomiR biogenesis // RNA Biology. 2021. Vol. 18. No. sup1. P. 430-438. doi
HSE University Scientists Win 2024 Best Russian Research Paper Competition
Leading scientists from HSE University have won the Scientific Category of the 2024 Best Russian-Language Scientific and Popular Science Works Competition by HSE University employees in the "Biology and Medicine" section for their research on predicting the effectiveness of chemotherapy with gemcitabine in patients with bladder cancer.
Russian Researchers Assess the Power of T-Cell Immune Response to Omicron BA.1 and BA.2
Scholars from HSE University and the RAS Institute of Bioorganic Chemistry have demonstrated the efficiency of T-cell immune response against the Omicron variant of SARS-CoV-2. In approximately 90% of vaccinated Europeans, T-cell immunity was as effective against Omicron as with other variants. The results of the study were published in PeerJ.